Pink Sheet is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Hyperion Therapeutics Inc., a biotech focused on orphan diseases, netted $53.5mm in its initial public offering of 5.75mm shares (including the overallotment) at $10. The company sold slightly more than the 4.2mm shares it planned, and fell short of its $11-13 range.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?